Title | Description |
|---|---|
| Trial ID | KF6005/07 |
| Compound | Cebranopadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | CORAL - Cebranopadol versus morphine prolonged-release in patients with chronic moderate to severe pain related to cancer |
| Indication | Chronic Pain, Cancer Pain |
| UTN | U1111-1143-1808 |
| CTG ID | NCT01964378 |
| CTIS ID (former EudraCT) | 2012-001316-35 |
| Trial status | Completed |
| FPI | October 29, 2013 |
| LPO | October 16, 2015 |
| Countries | Germany, United States |
| Gender | All |
| Age | >= 18 years of age |
| Results | Yes |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.